[Hepatocellular carcinoma in cirrhosis: semeiology and performance of magnetic resonance imaging and lipiodol computed tomography]
- PMID: 10219612
[Hepatocellular carcinoma in cirrhosis: semeiology and performance of magnetic resonance imaging and lipiodol computed tomography]
Abstract
Objectives: a) Describe hepatocellular semiology in magnetic resonance imaging and lipiodol computerized tomography in patients with cirrhosis, who are candidates for surgery; b) Clarify the respective roles of magnetic resonance imaging and lipiodol computerized tomography in hepatocellular detection.
Methods: Twenty four patients with suspected hepatocellular carcinoma underwent successive magnetic resonance imaging and lipiodol computerized tomography. Thirty-four of the 67 lesions seen by lipiodol computerized tomography and 28 of 52 lesions seen by magnetic resonance imaging were confirmed histologically.
Results: In lipiodol computerized tomography, 44% of hepatocellular carcinomas had a dense and homogeneous pattern; 24% had a homogeneous but slightly dense pattern. Sixteen distinct deposits were described: 4 were confirmed as hepatocellular carcinoma and 12 were not controlled histologically. In magnetic resonance imaging 57% of hepatocellular carcinomas have a high intensity on T1 and T2 weighted spin echo images, 38% were hyperintense on T2 and hypo or isointense on T1 weighted images. Eighty-six percent of hyperintense T1 and T2 weighted images were hepatocellular carcinoma. When the gold standard was histology, lipiodol computerized tomography sensitivity (81%) was higher than magnetic resonance imaging (68%). When the gold standard was lipiodol computerized tomography, the sensitivity of magnetic resonance imaging was 47 +/- 12%.
Conclusions: a) The sensitivity of lipiodol computerized tomography was better than resonance magnetic imaging; b) the homogeneous and slightly dense pattern corresponded to a hepatocellular carcinoma in 50% of cases; c) on magnetic resonance imaging any lesions with high intensity on T1 and T2 spin echo images strongly suggests hepatocellular carcinoma; d) if surgical resection after ultrasonography is being considered, the second step should be an magnetic resonance imaging.
Similar articles
-
[The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].Radiol Med. 1992 Nov;84(5):587-95. Radiol Med. 1992. PMID: 1335589 Italian.
-
[Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].Radiol Med. 1994 Oct;88(4):429-36. Radiol Med. 1994. PMID: 7997616 Clinical Trial. Italian.
-
Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT.Acta Radiol. 1996 Jan;37(1):69-74. doi: 10.1177/02841851960371P114. Acta Radiol. 1996. PMID: 8611328
-
[Computerized tomography with lipiodol in hepatocarcinoma. Assessment of its diagnostic accuracy with anatomo-pathological control].Radiol Med. 1998 Jul-Aug;96(1-2):81-6. Radiol Med. 1998. PMID: 9819623 Review. Italian.
-
Computed tomography and magnetic resonance imaging in diagnosing hepatocellular carcinoma.Ital J Gastroenterol. 1992 Feb;24(2):87-91. Ital J Gastroenterol. 1992. PMID: 1315593 Review.
Cited by
-
Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.World J Gastroenterol. 2002 Aug;8(4):658-62. doi: 10.3748/wjg.v8.i4.658. World J Gastroenterol. 2002. PMID: 12174374 Free PMC article.
-
Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.Front Oncol. 2021 Jul 2;11:621834. doi: 10.3389/fonc.2021.621834. eCollection 2021. Front Oncol. 2021. PMID: 34277397 Free PMC article.
-
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2. Cochrane Database Syst Rev. 2021. PMID: 34611889 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical